Tradewinds Capital Management LLC Increases Position in Thermo Fisher Scientific Inc (TMO)

Tradewinds Capital Management LLC boosted its stake in Thermo Fisher Scientific Inc (NYSE:TMO) by 0.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 968 shares of the medical research company’s stock after acquiring an additional 1 shares during the period. Tradewinds Capital Management LLC’s holdings in Thermo Fisher Scientific were worth $169,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Canada Pension Plan Investment Board raised its holdings in shares of Thermo Fisher Scientific by 56.3% in the second quarter. Canada Pension Plan Investment Board now owns 435,761 shares of the medical research company’s stock valued at $76,027,000 after buying an additional 156,962 shares during the last quarter. Arrow Financial Corp raised its holdings in shares of Thermo Fisher Scientific by 288.0% in the second quarter. Arrow Financial Corp now owns 2,328 shares of the medical research company’s stock valued at $406,000 after buying an additional 1,728 shares during the last quarter. Consolidated Investment Group LLC raised its holdings in shares of Thermo Fisher Scientific by 6.4% in the second quarter. Consolidated Investment Group LLC now owns 25,015 shares of the medical research company’s stock valued at $4,364,000 after buying an additional 1,500 shares during the last quarter. Rockland Trust Co. raised its holdings in shares of Thermo Fisher Scientific by 98.5% in the second quarter. Rockland Trust Co. now owns 53,761 shares of the medical research company’s stock valued at $9,380,000 after buying an additional 26,682 shares during the last quarter. Finally, Shine Investment Advisory Services Inc. purchased a new stake in shares of Thermo Fisher Scientific in the second quarter valued at about $113,000. 83.36% of the stock is owned by hedge funds and other institutional investors.

TMO has been the subject of a number of research reports. Deutsche Bank AG set a $200.00 target price on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a report on Saturday, June 10th. BidaskClub cut shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 27th. Citigroup Inc. reaffirmed a “buy” rating and issued a $201.00 target price (up from $182.00) on shares of Thermo Fisher Scientific in a report on Monday, July 10th. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $199.00 target price for the company in a report on Tuesday, July 11th. Finally, Wells Fargo & Company reaffirmed an “outperform” rating and issued a $200.00 target price (up from $195.00) on shares of Thermo Fisher Scientific in a report on Thursday, July 13th. Two equities research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $193.56.

COPYRIGHT VIOLATION NOTICE: This news story was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The legal version of this news story can be viewed at https://www.chaffeybreeze.com/2017/09/19/tradewinds-capital-management-llc-increases-position-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Inc (TMO) opened at 191.86 on Tuesday. The stock has a market capitalization of $74.85 billion, a PE ratio of 33.43 and a beta of 1.05. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $194.30. The company’s 50-day moving average is $180.67 and its 200 day moving average is $170.94.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.27 by $0.03. The firm had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. Thermo Fisher Scientific’s quarterly revenue was up 10.2% compared to the same quarter last year. During the same period last year, the firm posted $2.03 EPS. On average, analysts predict that Thermo Fisher Scientific Inc will post $9.35 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 15th will be given a $0.15 dividend. The ex-dividend date is Thursday, September 14th. This represents a $0.60 annualized dividend and a yield of 0.31%. Thermo Fisher Scientific’s dividend payout ratio is presently 10.45%.

In related news, Director C Martin Harris sold 360 shares of Thermo Fisher Scientific stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total value of $65,149.20. Following the sale, the director now directly owns 5,312 shares in the company, valued at approximately $961,312.64. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Jim P. Manzi sold 1,000 shares of Thermo Fisher Scientific stock in a transaction dated Thursday, August 17th. The shares were sold at an average price of $175.20, for a total transaction of $175,200.00. Following the completion of the sale, the director now owns 38,757 shares in the company, valued at $6,790,226.40. The disclosure for this sale can be found here. Over the last quarter, insiders sold 22,738 shares of company stock worth $4,021,512. 0.49% of the stock is currently owned by insiders.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply